Oyster Point Pharma, Inc.
OYST2023/1/3 下市- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. 已在 2023/1/3 下市;內部人最後一份 Form 4 在 2023/1/5 申報;2022 年第 4 季末有 53 家機構在 13F 申報持有,市值合計 $1.89 億;沒有大師持有。
SEC 申報
Oyster Point Pharma, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2023/1/13 | 8-K/A | 1.022.013.013.035.015.025.039.01 | 2023/1/3 | SEC | 目錄 |
| 2023/1/3 | 8-K | 1.022.013.013.035.015.025.039.01 | 2023/1/3 | SEC | 目錄 |
| 2022/11/10 | 10-Q | – | 2022/9/30 | SEC | 目錄 |
| 2022/11/10 | 8-K | 2.029.01 | 2022/11/10 | SEC | 目錄 |
| 2022/11/8 | 8-K | 1.019.01 | 2022/11/7 | SEC | 目錄 |
| 2022/11/7 | 8-K | 8.019.01 | 2022/11/7 | SEC | 目錄 |
| 2022/8/11 | 10-Q | – | 2022/6/30 | SEC | 目錄 |
| 2022/8/11 | 8-K | 2.029.01 | 2022/8/11 | SEC | 目錄 |
| 2022/7/12 | 8-K | 5.02 | 2022/7/6 | SEC | 目錄 |
| 2022/6/28 | 8-K | 2.055.028.019.01 | 2022/6/23 | SEC | 目錄 |
| 2022/6/8 | 8-K | 5.07 | 2022/6/3 | SEC | 目錄 |
| 2022/5/5 | 10-Q | – | 2022/3/31 | SEC | 目錄 |
| 2022/5/5 | 8-K | 2.029.01 | 2022/5/5 | SEC | 目錄 |
| 2022/3/18 | 8-K | 5.029.01 | 2022/3/14 | SEC | 目錄 |
| 2022/2/24 | 10-K | – | 2021/12/31 | SEC | 目錄 |
| 2022/2/24 | 8-K | 2.029.01 | 2022/2/24 | SEC | 目錄 |
| 2022/1/13 | 8-K | 5.02 | 2022/1/9 | SEC | 目錄 |
| 2021/11/4 | 10-Q | – | 2021/9/30 | SEC | 目錄 |
| 2021/11/4 | 8-K | 2.022.049.01 | 2021/11/4 | SEC | 目錄 |
| 2021/10/19 | 8-K | 1.019.01 | 2021/10/19 | SEC | 目錄 |
| 2021/10/18 | 8-K | 1.018.019.01 | 2021/10/18 | SEC | 目錄 |
| 2021/8/5 | 10-Q | – | 2021/6/30 | SEC | 目錄 |
| 2021/8/5 | 8-K | 2.029.01 | 2021/8/5 | SEC | 目錄 |
| 2021/8/2 | 8-K | 5.027.01 | 2021/7/30 | SEC | 目錄 |
| 2021/7/1 | 8-K | 7.018.019.01 | 2021/7/1 | SEC | 目錄 |
| 2021/6/10 | 8-K | 5.07 | 2021/6/4 | SEC | 目錄 |
| 2021/6/3 | 8-K | 8.019.01 | 2021/6/3 | SEC | 目錄 |
| 2021/5/6 | 10-Q | – | 2021/3/31 | SEC | 目錄 |
| 2021/5/6 | 8-K | 2.029.01 | 2021/5/6 | SEC | 目錄 |
| 2021/4/5 | 8-K | 5.027.019.01 | 2021/4/2 | SEC | 目錄 |
| 2021/3/2 | 8-K | 8.019.01 | 2021/3/2 | SEC | 目錄 |
| 2021/2/18 | 10-K | – | 2020/12/31 | SEC | 目錄 |
| 2021/2/18 | 8-K | 2.029.01 | 2021/2/18 | SEC | 目錄 |
| 2020/12/18 | 8-K | 8.019.01 | 2020/12/18 | SEC | 目錄 |
| 2020/12/2 | 8-K | 8.019.01 | 2020/12/1 | SEC | 目錄 |
| 2020/11/5 | 10-Q | – | 2020/9/30 | SEC | 目錄 |
| 2020/11/5 | 8-K | 2.029.01 | 2020/11/5 | SEC | 目錄 |
| 2020/11/5 | 8-K | 1.017.019.01 | 2020/11/5 | SEC | 目錄 |
| 2020/10/9 | 8-K | 5.027.019.01 | 2020/10/8 | SEC | 目錄 |
| 2020/8/5 | 10-Q | – | 2020/6/30 | SEC | 目錄 |
| 2020/8/5 | 8-K | 2.02 | 2020/8/5 | SEC | 目錄 |
| 2020/6/9 | 8-K | 7.01 | 2020/6/8 | SEC | 目錄 |
| 2020/6/5 | 8-K | 5.07 | 2020/6/5 | SEC | 目錄 |
| 2020/5/15 | 8-K | 8.019.01 | 2020/5/15 | SEC | 目錄 |
| 2020/5/11 | 10-Q | – | 2020/3/31 | SEC | 目錄 |
| 2020/5/11 | 8-K | 8.01 | 2020/5/11 | SEC | 目錄 |
| 2020/5/11 | 8-K | 2.029.01 | 2020/5/11 | SEC | 目錄 |
| 2020/3/30 | 8-K | 8.019.01 | 2020/3/30 | SEC | 目錄 |
| 2020/2/27 | 10-K | – | 2019/12/31 | SEC | 目錄 |
| 2020/2/27 | 8-K | 2.029.01 | 2020/2/27 | SEC | 目錄 |